Tricida, Inc. . Full-time Email Format
Pharmaceutical ManufacturingCalifornia, United States11-50 Employees
Tricida, Inc. is a pharmaceutical company based in South San Francisco, California, founded in August 2013. Its development focus is veverimer (TRC101), an oral, non-absorbed polymer intended to treat metabolic acidosis in patients with chronic kidney disease. Metabolic acidosis commonly accompanies CKD and is believed to accelerate disease progression and contribute to muscle wasting and bone density loss. The company targets CKD patients with metabolic acidosis and the clinicians who manage their care, seeking to provide a therapeutic option for this complication. In 2023, Tricida announced a leadership change with the departure of its Senior Vice President for Human Resources and Operations.